Fatma Zehra Hapil

Fatma Zehra Hapil

Auto-generated profile, based on publicly available information

Fatma Zehra Hapil

Department of Medical Biology, Faculty of Medicine, Akdeniz University, Antalya 07058, Turkiye

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2018 in Immunology
Verified
Journal Article
Open access
PDF file
FHFatma Zehra Hapil
Fatma Zehra Hapil
GWGerhard Wingender
Gerhard Wingender
Summary: The surface of mammalian bodies is colonized by a multitude of microbial organisms, which under normal conditions support the host and are considered beneficial commensals. This requires, however, that the composition of the commensal microbiota is tightly controlled and regulated. The host immune system plays an important role in the maintenance of this microbiota composition. Here we focus on the contribution of one particular immune cell type, invariant Natural Killer T (iNKT) cells, in this process. The iNKT cells are a unique subset of T cells characterized by two main features. First, they express an invariant T‐cell receptor that recognizes glycolipid antigens presented by CD1d, a non‐polymorphic major histocompatibility complex class I‐like molecule. Second, iNKT cells develop as effector/memory cells and swiftly exert effector functions, like cytokine production and cytotoxicity, after activation. We outline the influence that the mucosal microbiota can have on iNKT cells, and how iNKT cells contribute to the maintenance of the microbiota composition.

20 April 2021 in TURKISH JOURNAL OF BIOLOGY
Verified
Journal Article
Open access
FÇFatma Ece Çopuroğlu
Fatma Ece Çopuroğlu
FHFatma Zehra Hapi̇l
Fatma Zehra Hapi̇l
BYBurcak Yoldas
Burcak Yoldas
OÖOsman Nidai Özeş
Osman Nidai Özeş
TNF is a pleiotropic cytokine and shows its biological function by binding to its receptors called TNFR1 and TNFR2. While TNFR1 induces apoptosis by activation of caspase-8 via the "death domain", it also activates IKK alpha/ss, MKK3/6, MKK4/7 by activation of TAK1. Although the TNFR1 signaling pathway is known by in large, it is not known how AKT and MAPKs p38, ERK1/2, and JNK1/2 are activated. The presence of a proline-rich PPAP region, (P(448)PAP(451), a binding site for the SH3 domain-containing proteins) very close to the C-terminus promoted us to determine whether this region has any role in the TNFR1 signal transduction. To test this, the codons of P 448 and P 451 were changed to that of Alanin, GCG, via site-directed mutagenesis, and this plasmid was named as TNFR1-SH3-P/A. Subsequently, ectopically expressed the wild type TNFR1 and TNFR1-SH3-P/A in 293T cells and determined the levels of TNF-alpha-mediated phosphorylations of ERK, p38, JNK and AKT, NF-kB, and caspase-8 activation. While ectopic expression of our mutant diminished TNF alpha-mediated phosphorylations of p38, JNK, ERK and AKT, it increased NF-kB, and caspase-8 activations. In conclusion, TNF alpha-mediated ERK, AKT, JNK, p38 activations are affected by TNFR1 SH3 domain modifications.

27 February 2024 in TURKISH JOURNAL OF BIOLOGY
Verified
Journal Article
Open access
PDF file
FZFatma Zehra Hapi̇l Zevkli̇lEr
Fatma Zehra Hapi̇l Zevkli̇lEr
FÇFatma Ece Çopuroğlu
Fatma Ece Çopuroğlu
MEMustafa Gökhan Ertosun
Mustafa Gökhan Ertosun
UMUfuk Mert
Ufuk Mert
DÖDerya Özeş
Derya Özeş
OÖOsman Nidai Özeş
Osman Nidai Özeş
Background/aim: Tumor necrosis factor alpha (TNFα, a.k.a. TNF) is a pleiotropic cytokine that exerts most of its effects through type 1 TNF receptor (TNFR1). Following TNF binding, TNFR1 recruits TRADD (tumor necrosis factor receptor type 1-associated DEATH domain). This interaction triggers formation of signalosome complexes which have been claimed to induce apoptosis (via downstream caspase activations), inflammation (via NF-kappaB) and stress pathways (JNK & p38). However, the mechanism underlying TNF-induced ERK and AKT activation is not completely revealed. TNFR1 is known to constitutively bind c-Src and JAK2, and these enzymes were previously demonstrated to modulate TNF signaling. Therefore, we hypothesized that TNFR1 could be tyrosine phosphorylated by JAK2 and/or c-Src and TNF-induced ERK and Akt activation may be mediated by this phosphorylation. Materials and methods: Site-directed mutagenesis (SDM) was performed to substitute the two putative Tyrosine phosphorylation sites on TNFR1 (Y360 and Y401) with alanine (A) or with aspartic acid (D), to inhibit or mimic constitutive phosphorylation, respectively. In 293T cells transfected with mutated or wild type TNFR1, ERK and Akt activations were determined by western blot. TNFR1 interaction with c-Src, JAK2, p85 and Grb2 was examined by co-IP. NF-kB activation was measured by luciferase assay, while proliferation was measured by MTT and apoptosis was evaluated by colorimetric caspase 8/3 assays. For determination of necrosis rates, cellular DNA fragmentation ELISA was performed. Results: In this report, we show that TNFR1 is phosphorylated by JAK2 tyrosine kinase at Y401 and by c-Src at Y360 and Y401. Phosphorylation of Y360 and Y401 augments the interaction of Grb2 and PI3Kp85 with TNFR1. We also demonstrate that phosphomimetic mutations of Y360D and Y401D enhance ERK and Akt activation. Conclusion: TNFR1 is tyrosine phosphorylated by both c-Src and JAK2, triggering a “noncanonical” pathway, that activates ERK and Akt.

1 January 2020 in TURKISH JOURNAL OF BIOLOGY
Verified
Journal Article
Open access
MEMustafa Gökhan Ertosun
Mustafa Gökhan Ertosun
SDSayra Di̇lmaç
Sayra Di̇lmaç
FZFatma Zehra Hapi̇l Zevkli̇ler
Fatma Zehra Hapi̇l Zevkli̇ler
GTGamze Tanriover
Gamze Tanriover
SKSadi Koksoy
Sadi Koksoy
OÖOsman Ni̇dai̇ Özeş
Osman Ni̇dai̇ Özeş
E2F1 becomes activated during the G1 phase of the cell cycle, and posttranslational modifications modulate its activity. Activation of G-protein coupled receptors (GPCR) by many ligands induces the activation of adenylate cyclases and the production of cAMP, which activates the PKA enzyme. Activated PKA elicits its biological effect by phosphorylating the target proteins containing serine or threonine amino acids in the RxxS/T motif. Since PKA activation negatively regulates cell proliferation, we thought that activated PKA would negatively affect the activity of E2F1. In line with this, when we analyzed the amino acid sequence of E2F1, we found 3 hypothetical consensus PKA phosphorylation sites located at 127-130, 232-235, and 361-364 positions and RYET, RLLS, and RMGS sequences. After showing the binding and phosphorylation of E2F1 by PKA, we converted the codons of Threonine-130, Serine-235, and Serine-364 to Alanine and Glutamic acid codons on the eukaryotic E2F1 expression vector we had previously created. We confirmed the phosphorylation of T130, S235, and S364 by developing monoclonal antibodies against phospho-specific forms of these sites and showed that their phosphorylation is cell cycle-dependent. According to our results, PKA-mediated phosphorylation of E2F1 by PKA inhibits proliferation and glucose uptake and induces caspase-3 activation and senescence.

29 January 2026 in Blood Red Cells & Iron
Verified
Journal Article
Open access
AYAhmet Yildirim
Ahmet Yildirim
FHFatma Zehra Hapil
Fatma Zehra Hapil
NÖNihal ÖZTÜRK
Nihal ÖZTÜRK
UYUlku Arslan Yildiz
Ulku Arslan Yildiz
MCMelike Cengiz
Melike Cengiz
PUPinar Ulker
Pinar Ulker

14 July 2026 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
PDPelin Dilsiz
Pelin Dilsiz
FHFatma Zehra Hapil
Fatma Zehra Hapil